share_log

DA Davidson Maintains Neutral on Usana Health Sciences, Raises Price Target to $52.5

DA Davidson Maintains Neutral on Usana Health Sciences, Raises Price Target to $52.5

DA Davidson 对 Usana Health Sciences 保持中立,将目标价上调至52.
Benzinga Real-time News ·  2023/02/13 23:03

DA Davidson analyst Linda Bolton Weiser maintains Usana Health Sciences (NYSE:USNA) with a Neutral and raises the price target from $49 to $52.5.

Da Davidson分析师Linda Bolton Weiser维持Usana Health Science(纽约证券交易所代码:USNA)的中性,并将目标价从49美元上调至52.5美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发